Intensive Case Diabetes Management (ICDM) to Prevent Readmission
- Conditions
- Diabetes
- Interventions
- Other: Intensive Diabetes Case Management
- Registration Number
- NCT02230488
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
The purpose of this study is to assess whether intensive case management interventions by a diabetes team, led by an endocrinologist and certified diabetes educator, can prevent \<31 day readmission in previously identified high risk patients with diabetes.The procedures of the study will focus on managing the patient's diabetes and diabetes education while in the hospital, decreasing the patient's risk for hypoglycemia and hyperglycemia in the hospital, and assist in the patient's diabetes management plan for a safe discharge.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
- Patients admitted with a diagnosis of diabetes, Patients with a previous history of Pharmacy Expert System (PES) alert, Enrollment in research must be within 24 hours of admission
- Patients transferred from institutionalized care, Patients who already plan to move to institutionalized care, Patients with severe co-morbidities (e.g. terminal cancer), Patients admitted for surgery within 24 hours, Patients who are unwilling or unable to give written consent (e.g. dementia), Patients who are homeless, Patients previously admitted to the diabetes endocrine service
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Intensive Diabetes Case Management Intensive Diabetes Case Management Intensive Case Diabetes Management : A diabetes team , led by an endocrinologist and CDE, will manage the patients diabetes while in the hospital and will assist with the patient's discharge Diabetes endocrine consult team will manage the patient's diabetes daily while in the hospital Discharge diabetes medication reconciliation per research team Research team will provide 30 day supply of diabetes medication/supplies at discharge Research Team will provide 30 day supply of glucose test strips at discharge Discharge telecommunication from endocrinologist to primary care provider Patient-centered discharge diabetes education per research CDE Post-discharge 48-72 hours continuity check per phone by a diabetes research team member/CDE
- Primary Outcome Measures
Name Time Method Prevent <31 day readmission The length of time between hospital discharge and readmission 31 days Primary outcome measure is to assess whether an intensive case management intervention by a diabetes team, led by an endocrinologist and a certified diabetes educator (CDE) , can prevent a \<31 day readmission in previously identified high risk patients with diabetes compared to standard/usual care.
- Secondary Outcome Measures
Name Time Method improve overall glycemic management Upon the participant's consent (within 24 hours of hospital admission) to hospital discharge- the average length of stay is five days To examine whether intensive case management intervention per endocrinologist and CDE during hospital stay prevents hypoglycemia \<70mg/dl, severe hypoglycemia \<40mg/dl, and improves overall glycemic management (100-180 mg/dl) compared to standard/usual care.
Trial Locations
- Locations (1)
Barnes-Jewish Hospital
🇺🇸St. Louis, Missouri, United States